XML 50 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Shareholders' Equity
 12 Months Ended
Dec. 31, 2018
Stockholders' Equity Note [Abstract]  
Shareholders' Equity [Text Block] Shareholders’ Equity
The following tables provide the amounts related to each component of OCI:
 
Year Ended December 31, 2018
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
(in millions)
Net unrealized gains (losses) on securities:
 
 
 
 
 
Net unrealized gains (losses) on securities arising during the period (1)
$
(1,039
)
 
$
237

 
$
(802
)
Reclassification of net (gains) losses on securities included in net income (2)
(9
)
 
2

 
(7
)
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables
435

 
(91
)
 
344

Net unrealized gains (losses) on securities
(613
)
 
148

 
(465
)
Defined benefit plans:
 
 
 
 
 
Net gain (loss) arising during the period
(30
)
 
7

 
(23
)
Defined benefit plans
(30
)
 
7

 
(23
)
Foreign currency translation
(32
)
 
1

 
(31
)
Total other comprehensive income (loss)
$
(675
)
 
$
156

 
$
(519
)
 
Year Ended December 31, 2017
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
(in millions)
Net unrealized gains (losses) on securities:
 
 
 
 
 
Net unrealized gains (losses) on securities arising during the period (1)
$
243

 
$
(77
)
 
$
166

Reclassification of net (gains) losses on securities included in net income (2)
(55
)
 
19

 
(36
)
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables
(180
)
 
57

 
(123
)
Net unrealized gains (losses) on securities
8

 
(1
)
 
7

Net unrealized gains (losses) on derivatives:
 
 
 
 
 
Reclassification of net (gains) losses on derivatives included in net income (3)
5

 
(2
)
 
3

Net unrealized gains (losses) on derivatives
5

 
(2
)
 
3

Defined benefit plans:
 
 
 
 
 
Prior service credit
2

 
(1
)
 
1

Net gain (loss) arising during the period
38

 
(11
)
 
27

Defined benefit plans
40

 
(12
)
 
28

Foreign currency translation
74

 
(82
)
(4) 
(8
)
Other
(1
)
 
—

 
(1
)
Total other comprehensive income (loss)
$
126

 
$
(97
)
 
$
29

 
Year Ended December 31, 2016
Pretax
 
Income Tax Benefit (Expense)
 
Net of Tax
(in millions)
Net unrealized gains (losses) on securities:
 
 
 
 
 
Net unrealized gains (losses) on securities arising during the period (1)
$
339

 
$
(121
)
 
$
218

Reclassification of net (gains) losses on securities included in net income (2)
(22
)
 
8

 
(14
)
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables
(242
)
 
85

 
(157
)
Net unrealized gains (losses) on securities
75

 
(28
)
 
47

Net unrealized gains (losses) on derivatives:
 
 
 
 
 
Reclassification of net (gains) losses on derivatives included in net income (3)
6

 
(2
)
 
4

Net unrealized gains (losses) on derivatives
6

 
(2
)
 
4

Defined benefit plans:
 
 
 
 
 
Net gain (loss) arising during the period
(45
)
 
11

 
(34
)
Defined benefit plans
(45
)
 
11

 
(34
)
Foreign currency translation
(117
)
 
41

 
(76
)
Total other comprehensive income (loss)
$
(81
)
 
$
22

 
$
(59
)
(1) Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income (loss) during the period.
(2) Reclassification amounts are recorded in net investment income.
(3) Includes a $2 million, $2 million and $1 million pretax gain reclassified to interest and debt expenses and a $2 million, $5 million and $6 million pretax loss reclassified to net investment income for the years ended December 31, 2018, 2017 and 2016, respectively.
(4) Includes an $87 million decrease to OCI related to deferred taxes on currency translations adjustments.
Other comprehensive income (loss) related to net unrealized securities gains (losses) includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit other-than-temporary impairment losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.
The following table presents the changes in the balances of each component of AOCI, net of tax:
 
Net Unrealized Gains (Losses) on Securities
 
Net Unrealized Gains (Losses) on Derivatives
 
Defined Benefit Plans
 
Foreign Currency Translation
 
Other
 
Total
(in millions)
Balance, January 1, 2016
$
426

 
$
1

 
$
(91
)
 
$
(83
)
 
$
—

 
$
253

Cumulative effect of change in accounting policies
6

 
—

 
—

 
—

 
—

 
6

OCI before reclassifications
61

 
—

 
(39
)
 
(76
)
 
—

 
(54
)
Amounts reclassified from AOCI
(14
)
 
4

 
5

 
—

 
—

 
(5
)
Total OCI
47

 
4

 
(34
)
 
(76
)
 
—

 
(59
)
Balance, December 31, 2016
479

(1) 
5

 
(125
)
 
(159
)
 
—

 
200

OCI before reclassifications
43

 
—

 
20

 
(8
)
 
(1
)
 
54

Amounts reclassified from AOCI
(36
)
 
3

 
8

 
—

 
—

 
(25
)
Total OCI
7

 
3

 
28

 
(8
)
 
(1
)
 
29

Balance, December 31, 2017
486

(1) 
8

 
(97
)
 
(167
)
 
(1
)
 
229

Cumulative effect of change in accounting policies
(1
)
 
—

 
—

 
—

 
—

 
(1
)
OCI before reclassifications
(458
)
 
—

 
(36
)
 
(31
)
 
—

 
(525
)
Amounts reclassified from AOCI
(7
)
 
—

 
13

 
—

 
—

 
6

Total OCI
(465
)
 
—

 
(23
)
 
(31
)
 
—

 
(519
)
Balance, December 31, 2018
$
20

(1) 
$
8

 
$
(120
)
 
$
(198
)
 
$
(1
)
 
$
(291
)
(1) Includes $1 million, $1 million and $4 million of noncredit related impairments on securities and net unrealized gains (losses) on previously impaired securities as of December 31, 2018, 2017 and 2016, respectively.
For the years ended December 31, 2018, 2017 and 2016, the Company repurchased a total of 11.3 million shares, 9.9 million shares and 17.6 million shares, respectively, of its common stock for an aggregate cost of $1.6 billion, $1.3 billion and $1.7 billion, respectively. In April 2017, the Company's Board of Directors authorized an expenditure of up to $2.5 billion for the repurchase of shares of the Company’s common stock through June 30, 2019. As of December 31, 2018, the Company had $509 million remaining under its share repurchase authorizations. In February 2019, the Company’s Board of Directors authorized an additional repurchase up to $2.5 billion of the Company’s common stock through March 31, 2021.
The Company may also reacquire shares of its common stock under its share-based compensation plans related to restricted stock awards and certain option exercises. The holders of restricted shares may elect to surrender a portion of their shares on the vesting date to cover their income tax obligation. These vested restricted shares are reacquired by the Company and the Company’s payment of the holders’ income tax obligations are recorded as a treasury share purchase.
For the years ended December 31, 2018, 2017 and 2016, the Company reacquired 0.3 million shares, 0.3 million shares and 0.3 million shares, respectively, of its common stock through the surrender of shares upon vesting and paid in the aggregate $44 million, $33 million and $29 million, respectively, related to the holders’ income tax obligations on the vesting date. Option holders may elect to net settle their vested awards resulting in the surrender of the number of shares required to cover the strike price and tax obligation of the options exercised. These shares are reacquired by the Company and recorded as treasury shares. For the years ended December 31, 2018, 2017 and 2016, the Company reacquired 0.5 million shares, 2.2 million shares and 0.5 million shares, respectively, of its common stock through the net settlement of options for an aggregate value of $85 million, $298 million and $48 million, respectively.
For the years ended December 31, 2018, 2017 and 2016, respectively, the Company reissued 0.8 million, 0.8 million and 0.9 million treasury shares, respectively, for restricted stock award grants, PSUs, and issuance of shares vested under advisor deferred compensation plans.